These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 4339394)

  • 1. Degradation of angiotensin II by plasmin.
    Dudek G; Latallo ZS; Prokopowicz J; Worowski K
    Br J Pharmacol; 1972 May; 45(1):60-3. PubMed ID: 4339394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of specificity of endopeptidases by combined high-performance liquid chromatography and amino acid analysis.
    Wilk S; Orlowski M
    J Chromatogr; 1982 Nov; 249(1):121-9. PubMed ID: 6757262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide inhibitors for angiotensin I-converting enzyme from thermolysin digest of dried bonito.
    Yokoyama K; Chiba H; Yoshikawa M
    Biosci Biotechnol Biochem; 1992 Oct; 56(10):1541-5. PubMed ID: 1369054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Action of brain cathepsin B, cathepsin D, and high-molecular-weight aspartic proteinase on angiotensins I and II.
    Azaryan A; Barkhudaryan N; Galoyan A; Lajtha A
    Neurochem Res; 1985 Nov; 10(11):1525-32. PubMed ID: 3911093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum aminopeptidases, "angiotensinase," and hypertension. I. Degradation of angiotensin II by human serum.
    Nagatsu I; Gillespie L; Folk JE; Glenner GG
    Biochem Pharmacol; 1965 May; 14(5):721-8. PubMed ID: 4284642
    [No Abstract]   [Full Text] [Related]  

  • 6. The NH2-terminal amino acids of the fibrinogen degradation products. Implications for fibrinogen structure.
    Marder VJ; Budzynski AZ
    Thromb Diath Haemorrh Suppl; 1973; 56():127-35. PubMed ID: 4281939
    [No Abstract]   [Full Text] [Related]  

  • 7. Identification of molecular forms of plasminogen and plasmin-inhibitor complexes in urokinase-activated human plasma.
    Müllertz S; Thorsen S; Sottrup-Jensen L
    Biochem J; 1984 Oct; 223(1):169-77. PubMed ID: 6208893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Active metabolites derived from angiotensin II].
    Chansel D; Ardaillou R
    Nephrologie; 1998; 19(7):427-32. PubMed ID: 9857379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of substrates with 7-amino-3-trifluoromethylcoumarine (AFC) leaving group in the localization of protease activities in situ.
    Lojda Z
    Acta Histochem; 1996 Apr; 98(2):215-28. PubMed ID: 8739306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent studies of the synthetic selective inhibitors; with special reference to non-plasmin fibrinolytic enzyme, plasmin and plasma-kallikrein.
    Okamoto S; Okamoto U; Hijikata-Okunomiya A; Wanaka K; Okada Y
    Thromb Res Suppl; 1988; 8():131-41. PubMed ID: 2974647
    [No Abstract]   [Full Text] [Related]  

  • 11. The amino acid sequence of hypertensin. II.
    SKEGGS LT; LENTZ KE; KAHN JR; SHUMWAY NP; WOODS KR
    J Exp Med; 1956 Aug; 104(2):193-7. PubMed ID: 13345964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The amino acid composition of hypertensin II and its biochemical relationship to hypertensin I.
    LENTZ KE; SKEGGS LT; WOODS KR; KAHN JR; SHUMWAY NP
    J Exp Med; 1956 Aug; 104(2):183-91. PubMed ID: 13345963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic study of the effect of heparin on the amidase activity of trypsin, plasmin and urokinase.
    Yomtova VM; Stambolieva NA; Blagoev BM
    Thromb Haemost; 1983 Jun; 49(3):199-203. PubMed ID: 6224310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial inactivation of angiotensin II by plasmin.
    Prokopowicz J; Worowski K; Niewiarowski S
    Thromb Diath Haemorrh; 1969 Feb; 21(1):166-7. PubMed ID: 4304361
    [No Abstract]   [Full Text] [Related]  

  • 15. Degradation of fibrinogen by plasmin: physicochemical characteristics and their correlation to antithrombic activity.
    Triantaphyllopoulos E
    Thromb Diath Haemorrh Suppl; 1973; 56():91-112. PubMed ID: 4281941
    [No Abstract]   [Full Text] [Related]  

  • 16. Isolation and amino acid composition of human angiotensin I.
    Arakawa K; Nakatani M; Minohara A; Nakamura M
    Biochem J; 1967 Sep; 104(3):900-6. PubMed ID: 4292882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the peptide bond specificity and the essential groups of an acid proteinase from Aspergillus fumigatus.
    Panneerselvam M; Dhar SC
    Ital J Biochem; 1981; 30(3):207-16. PubMed ID: 7024192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New class of sensitive and selective fluorogenic substrates for serine proteinases. Amino acid and dipeptide derivatives of rhodamine.
    Leytus SP; Patterson WL; Mangel WF
    Biochem J; 1983 Nov; 215(2):253-60. PubMed ID: 6228222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Action of two thiol proteinases from the spleen which are active in neutral media on vasoactive peptides].
    Lokshina LA; Egorova TP; Orekhovich VN
    Biokhimiia; 1983 Jun; 48(6):951-8. PubMed ID: 6349701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic inactivation of val 5 angiotensin II amide (Hypertensin), val 5 angiotensin II free acid and adrenaline in immature and adult rabbits.
    Broughton Pipkin F
    J Physiol; 1972 Sep; 225(2):35P-36P. PubMed ID: 4342296
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.